Arkolith/Insider Trading/THRX/Form 4

Orbimed Advisors LLC

Director, 10% OwnerTheseus Pharmaceuticals, Inc. (THRX) · full profile →Form 4 · filed Jul 19, 2023
Net Buying
Open-Market Buys
$1.5M
Open-Market Sells
$0
Net Open-Market Flow
$1.5M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2023Buy(P)328K$3.05$1.0M17.1M
Jul 17, 2023Buy(P)151K$3.05$462K651K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-23-000760) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML